S80537 |
Dabigatran (BIBR 953) |
源叶(MedMol) | 95%(HPLC) |
- 提示:详情请下载说明书。
- 产品描述: Dabigatran (BIBR 953), an oral anticoagulant, is a reversible, potent, competitive direct thrombin inhibitor (Ki=4.5 nM). Dabigatran (BIBR 953) also inhibits thrombin-induced platelet aggregation (IC50=10 nM)
- 靶点: Ki: 4.5 nM (thrombin);Thrombin
- 体内研究:
Dabigatran (0.01-0.1 mg/kg; i.v.) inhibits clot formation with an ED50 of 0.033 mg/kg in Wessler model
- 参考文献:
1. Wienen W, Stassen JM, Priepke H, In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally activeprodrug, dabigatran etexilate. Thromb Haemost. 2007 Jul;98(1):155-62. 2. Hauel NH, et al. Structure-based design of novel potent nonpeptide thrombin inhibitors. J Med Chem. 2002 Apr 25;45(9):1757-66. 3. Wienen W, et al. Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in rats. Thromb Haemost. 2007 Aug;98(2):333-8.
- 溶解性: 0.1 M HCL : 12.5 mg/mL (26.51 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) DMSO : < 1 mg/mL (insoluble or slightly soluble)
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.121 ml 10.604 ml 21.208 ml 5 mM 0.424 ml 2.121 ml 4.242 ml 10 mM 0.212 ml 1.06 ml 2.121 ml 50 mM 0.042 ml 0.212 ml 0.424 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
- 2. [IF=6.057] Ghazala Ashraf et al."Extension of duplex specific nuclease sensing application with RNA aptamer."Talanta. 2022 May;242:123314
- 1. 袁冬冬,王亚蕾,张寒娟,王高彪,郭丽萍,可钰.LC-MS/MS法测定中原汉族房颤患者利伐沙班血浆药物浓度[J].药物分析杂志,2020,40(08):1399-1404.
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)